This post was originally published on this site.
Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up to 6 months after COVID-19 infection, according to data published in Arthritis & Rheumatology.
“Longer duration of SARS-CoV-2 antigen persistence in the blood has been associated with various outcomes including higher risk of post-acute sequelae of COVID-19,” Naomi J. Patel, MD, MPH, from the division of rheumatology, inflammation and immunity at Mass General Brigham, told Healio. “Individuals with systemic autoimmune rheumatic diseases (SARDs) are